Regeneron Pharma(REGN.US)

Last Updated 19:00:00 ET
longbridge loading

Pre-market trend | Regeneron Pharma (REGN) plummeted nearly 10% on May 18, is short interest accelerating?

Technical Forecast·
US
REGN
+1.21%
US
IXJ
+1.08%
US
BBH
+0.83%
Technical Forecast·
US
REGN
+1.21%
US
IXJ
+1.08%
US
BBH
+0.83%

Regeneron signs $2.32bn deal with Parabilis for Helicon conjugates

Pharmaceutical Technology·
US
REGN
+1.21%
Pharmaceutical Technology·
US
REGN
+1.21%

18:24 ETRegeneron Pharmaceuticals Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Regeneron Pharmaceuticals (REGN)

prnewswire·
US
REGN
+1.21%
US
ARKG
-0.85%
US
VHT
+1.14%
prnewswire·
US
REGN
+1.21%
US
ARKG
-0.85%
US
VHT
+1.14%

Health Care Up on Rotation Into Lagging Sectors — Health Care Roundup

MorningStar·
US
REGN
+1.21%
US
PBE
+0.47%
US
XLV
+1.28%
MorningStar·
US
REGN
+1.21%
US
PBE
+0.47%
US
XLV
+1.28%

Equity Markets Mixed as Trump Aborts Plan to Attack Iran

fidelity·
US
D
+0.96%
US
NVDL
-1.52%
US
NVDX
-1.56%
fidelity·
US
D
+0.96%
US
NVDL
-1.52%
US
NVDX
-1.56%

Regeneron Sinks 10% on Failed Phase 3 Melanoma Trial. What Comes Next for REGN Stock.

Barchart Option·
US
REGN
+1.21%
Barchart Option·
US
REGN
+1.21%
© 2026 Longbridge｜Disclaimer